Hanefeld M - Search Results

1

Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review.

Hanefeld M, Duetting E, Bramlage P. Hanefeld M, et al. Cardiovasc Diabetol. 2013 Sep 21;12:135. doi: 10.1186/1475-2840-12-135. Cardiovasc Diabetol. 2013. PMID: 24053606 Free PMC article. Review.

2

Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trial.

Hanefeld M, Bramlage P. Hanefeld M, et al. Curr Diab Rep. 2013 Jun;13(3):342-9. doi: 10.1007/s11892-013-0366-z. Curr Diab Rep. 2013. PMID: 23397557 Free PMC article. Review.

3

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes.

Tschöpe D, Hanefeld M, Meier JJ, Gitt AK, Halle M, Bramlage P, Schumm-Draeger PM. Tschöpe D, et al. Among authors: hanefeld m. Cardiovasc Diabetol. 2013 Apr 10;12:62. doi: 10.1186/1475-2840-12-62. Cardiovasc Diabetol. 2013. PMID: 23574917 Free PMC article. Review.

4

Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?

Gitt AK, Halle M, Hanefeld M, Kellerer M, Marx N, Meier JJ, Schumm-Draeger PM, Bramlage P, Tschöpe D. Gitt AK, et al. Among authors: hanefeld m. Eur J Heart Fail. 2012 Dec;14(12):1389-400. doi: 10.1093/eurjhf/hfs136. Epub 2012 Sep 13. Eur J Heart Fail. 2012. PMID: 22977264 Free article. Review.

5

Predictors of response to early basal insulin treatment in patients with type 2 diabetes--the EARLY experience.

Hanefeld M, Fleischmann H, Schiffhorst G, Bramlage P. Hanefeld M, et al. Diabetes Technol Ther. 2014 Apr;16(4):241-6. doi: 10.1089/dia.2013.0246. Epub 2013 Nov 14. Diabetes Technol Ther. 2014. PMID: 24229089

6

[Diabetes and heart failure: a practically oriented critical appraisal].

Halle M, Gitt AK, Hanefeld M, Kellerer M, Marx N, Meier JJ, Schumm-Draeger PM, Bramlage P, Tschoepe D. Halle M, et al. Among authors: hanefeld m. Dtsch Med Wochenschr. 2012 Mar;137(9):437-41. doi: 10.1055/s-0031-1298982. Epub 2012 Feb 21. Dtsch Med Wochenschr. 2012. PMID: 22354800 Review. German.

7

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study.

Hanefeld M, Pfützner A, Forst T, Kleine I, Fuchs W. Hanefeld M, et al. Cardiovasc Diabetol. 2011 Jul 14;10:65. doi: 10.1186/1475-2840-10-65. Cardiovasc Diabetol. 2011. PMID: 21756323 Free PMC article. Clinical Trial.

8

The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL.

Hanefeld M, Traylor L, Gao L, Landgraf W. Hanefeld M, et al. Cardiovasc Diabetol. 2017 May 19;16(1):66. doi: 10.1186/s12933-017-0548-0. Cardiovasc Diabetol. 2017. PMID: 28526014 Free PMC article.

9

Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study.

Hanefeld M, Koehler C, Gallo S, Benke I, Ott P. Hanefeld M, et al. Cardiovasc Diabetol. 2007 Apr 26;6:13. doi: 10.1186/1475-2840-6-13. Cardiovasc Diabetol. 2007. PMID: 17462080 Free PMC article.

10

Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes.

Hanefeld M. Hanefeld M. Cardiovasc Diabetol. 2007 Aug 15;6:20. doi: 10.1186/1475-2840-6-20. Cardiovasc Diabetol. 2007. PMID: 17697384 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page